Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Diazald → 2-benzyl 3-methyl (2S,3S,5S)-1-benzyl-5-methoxypiperidine-2,3-dicarboxylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Diazald | HCID 6628 | — |
| 반응물 | Diazomethane | HCID 9550 | — |
| 반응물 | 2-benzyl 3-methyl(2S,3S,5S)-1-benzyl-5-hydroxypiperidine-2,3-dicarboxylate | HCID 86621490 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 생성물 | 2-benzyl 3-methyl (2S,3S,5S)-1-benzyl-5-methoxypiperidine-2,3-dicarboxylate | HCID 131731930 | 3.2% |
반응 단계
Diazomethane was generated (from 5 g of Diazald) and distilled together with ether into a mixture of 2-benzyl 3-methyl(2S,3S,5S)-1-benzyl-5-hydroxypiperidine-2,3-dicarboxylate (0.60 g, 0.0016 mol) and around 1 g of silica gel in 10 mL of ether. After distillation, the mixture was stirred at rt overnight. The mixture was diluted with methylene chloride, filtered to remove silica gel. The filtration was concentrated to dry and the resulting residue was applied on column, eluting with 0 to 40% EtOAc in Hexane, to yield the methyl ether compound (20 mg, 3.2%). MS (ESI): (M+H)+=398.1.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09440958B2 |
| 출처 데이터셋 | uspto-grants-2016_09 |
| ORD ID | ord-d6b50734fdab42abaef84eeb7dbd4c9d |
| 출처 메모 | uspto-grants-2016_09 |